Insider · CIK 0002037442
Dylan Hartley
Files at OKUR (OnKure Therapeutics, Inc.). First filing -, latest -.
In brief
Dylan Hartley files SEC Form 4 as officer at OKUR (OnKure Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dylan Hartley has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Aug 11, 2026 |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -137,603 | - | - | 0 | Aug 11, 2026 |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +137,603 | - | - | 137,603 | Aug 11, 2026 |
| Apr 1, 2026 | OKUR OnKure Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +110,000 | $0.00 | $0 | 110,000 | Apr 3, 2026 |
| Jan 27, 2025 | OKUR OnKure Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jan 29, 2025 |
Questions about Dylan Hartley
Answered from the filings on this page, as of the latest one.
Is Dylan Hartley buying or selling?
Dylan Hartley has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dylan Hartley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dylan Hartley has 0.
Where does Dylan Hartley file Form 4?
Dylan Hartley has filed Form 4 at OKUR (OnKure Therapeutics, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.